-
1
-
-
0024238226
-
Clinical pharmacokinetics of carboplatin
-
WJ van der Vijgh 1991 Clinical pharmacokinetics of carboplatin Clin Pharmacokinet 21 4 242 261 (Pubitemid 19014767)
-
(1988)
Journal of Clinical Pharmacology
, vol.28
, Issue.3
, pp. 208-215
-
-
Oguri, S.1
Sakakibara, T.2
Mase, H.3
Shimizu, T.4
Ishikawa, K.5
Kimura, K.6
Smyth, R.D.7
-
2
-
-
0035998753
-
Toxicity of high-dose carboplatin: Ultrafiltered and not total plasma pharmacokinetics is of clinical relevance
-
DOI 10.1177/009127002401102704
-
C Kloft W Siegert J Beyer U Jaehde 2002 Toxicity of high-dose carboplatin: ultrafiltered and not total plasma pharmacokinetics is of clinical relevance J Clin Pharmacol 42 7 762 773 (Pubitemid 34663533)
-
(2002)
Journal of Clinical Pharmacology
, vol.42
, Issue.7
, pp. 762-773
-
-
Kloft, C.1
Siegert, W.2
Beyer, J.3
Jaehde, U.4
-
3
-
-
0024440650
-
Carboplatin dosage: Prospective evaluation of a simple formula based on renal function
-
AH Calvert DR Newell LA Gumbrell S O'Reilly M Burnell FE Boxall 1989 Carboplatin dosage: prospective evaluation of a simple formula based on renal function J Clin Oncol 7 11 1748 1756 (Pubitemid 19272848)
-
(1989)
Journal of Clinical Oncology
, vol.7
, Issue.11
, pp. 1748-1756
-
-
Calvert, A.H.1
Newell, D.R.2
Gumbrell, L.A.3
O'Reilly, S.4
Burnell, M.5
Boxall, F.E.6
Siddik, Z.H.7
Judson, I.R.8
Gore, M.E.9
Wiltshaw, E.10
-
4
-
-
0016916438
-
Prediction of creatinine clearance from serum creatinine
-
DW Cockcroft MH Gault 1976 Prediction of creatinine clearance from serum creatinine Nephron 16 1 31 41
-
(1976)
Nephron
, vol.16
, Issue.1
, pp. 31-41
-
-
Cockcroft, D.W.1
Gault, M.H.2
-
6
-
-
0032423228
-
Predictive performance of ten equations for estimating creatinine clearance in cardiac patients
-
DOI 10.1345/aph.18122
-
SA Spinler JJ Nawarskas EG Boyce JE Connors SL Charland S Goldfarb 1998 Predictive performance of ten equations for estimating creatinine clearance in cardiac patients Iohexol Cooperative Study Group Ann Pharmacother 32 12 1275 1283 (Pubitemid 29013348)
-
(1998)
Annals of Pharmacotherapy
, vol.32
, Issue.12
, pp. 1275-1283
-
-
Spinler, S.A.1
-
7
-
-
0036018898
-
Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin
-
DOI 10.1093/annonc/mdf052
-
ME de Jonge RA Mathot SM van Dam JH Beijnen S Rodenhuis 2002 Extremely high exposures in an obese patient receiving high-dose cyclophosphamide, thiotepa and carboplatin Cancer Chemother Pharmacol 50 3 251 255 (Pubitemid 34704997)
-
(2002)
Annals of Oncology
, vol.13
, Issue.3
, pp. 374-384
-
-
Huitema, A.D.R.1
Spaander, M.2
Mathot, R.A.A.3
Tibben, M.M.4
Holtkamp, M.J.5
Beijnen, J.H.6
Rodenhuis, S.7
-
8
-
-
28844446324
-
Prospective evaluation of carboplatin AUC dosing in patients with a BMI 27 or Cachexia
-
DOI 10.1007/s00280-005-0012-9
-
JD Herrington HT Tran MW Riggs 2006 Prospective evaluation of carboplatin AUC dosing in patients with a BMI > or =27 or cachexia Cancer Chemother Pharmacol 57 2 241 247 (Pubitemid 41779844)
-
(2006)
Cancer Chemotherapy and Pharmacology
, vol.57
, Issue.2
, pp. 241-247
-
-
Herrington, J.D.1
Tran, H.T.2
Riggs, M.W.3
-
9
-
-
0023943265
-
Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass
-
DOI 10.1016/0002-9343(88)90310-5
-
DE Salazar GB Corcoran 1988 Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass Am J Med 84 6 1053 1060 (Pubitemid 18150084)
-
(1988)
American Journal of Medicine
, vol.84
, Issue.6
, pp. 1053-1060
-
-
Salazar, D.E.1
Corcoran, G.B.2
-
10
-
-
1842426659
-
Bayesian Pharmacokinetically Guided Dosing of Paclitaxel in Patients with Non-Small Cell Lung Cancer
-
DOI 10.1158/1078-0432.CCR-03-0060
-
ME De Jonge HJ Van den Bongard ADR Huitema RA Mathot H Rosing P Baas 2004 Bayesian pharmacokinetically guided dosing of paclitaxel in patients with non-small cell lung cancer Clin Cancer Res 10 7 2237 2244 (Pubitemid 38445680)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.7
, pp. 2237-2244
-
-
De Jonge, M.E.1
Van Den Bongard, H.J.G.D.2
Huitema, A.D.R.3
Mathot, R.A.A.4
Rosing, H.5
Baas, P.6
Van Zandwijk, N.7
Beijnen, J.H.8
Schellens, J.H.M.9
-
11
-
-
0036018898
-
Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin
-
DOI 10.1093/annonc/mdf052
-
ADR Huitema M Spaander RAA Mathot MM Tibben MJ Holtkamp JH Beijnen 2002 Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin Ann Oncol 13 3 374 384 (Pubitemid 34704997)
-
(2002)
Annals of Oncology
, vol.13
, Issue.3
, pp. 374-384
-
-
Huitema, A.D.R.1
Spaander, M.2
Mathot, R.A.A.3
Tibben, M.M.4
Holtkamp, M.J.5
Beijnen, J.H.6
Rodenhuis, S.7
-
12
-
-
0030986627
-
Phase i and pharmacologic study of the combination paclitaxel and carboplatin as first-line chemotherapy in stage III and IV ovarian cancer
-
MT Huizing LJ van Warmerdam H Rosing MC Schaefers A Lai TJ Helmerhorst 1997 Phase I and pharmacologic study of the combination paclitaxel and carboplatin as first-line chemotherapy in stage III and IV ovarian cancer J Clin Oncol 15 5 1953 1964 (Pubitemid 27209526)
-
(1997)
Journal of Clinical Oncology
, vol.15
, Issue.5
, pp. 1953-1964
-
-
Huizing, M.T.1
Van Warmerdam, L.J.C.2
Rosing, H.3
Schaefers, M.C.W.4
Lai, A.5
Helmerhorst, T.J.M.6
Veenhof, C.H.N.7
Birkhofer, M.J.8
Rodenhuis, S.9
Beijnen, J.H.10
Ten Bokkel Huinink, W.W.11
-
13
-
-
8044220286
-
Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer
-
MT Huizing G Giaccone LJ van Warmerdam H Rosing PJ Bakker JB Vermorken 1997 Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre J Clin Oncol 15 1 317 329 (Pubitemid 27020590)
-
(1997)
Journal of Clinical Oncology
, vol.15
, Issue.1
, pp. 317-329
-
-
Huizing, M.T.1
Giaccone, G.2
Van Warmerdam, L.J.C.3
Rosing, H.4
Bakker, P.J.M.5
Vermorken, J.B.6
Postmus, P.E.7
Van Zandwijk, N.8
Koolen, M.G.J.9
Ten Bokkel Huinink, W.W.10
Van Der Vijgh, W.J.F.11
Bierhorst, F.J.12
Lai, A.13
Dalesio, O.14
Pinedo, H.M.15
Veenhof, C.H.N.16
Beijnen, J.H.17
-
14
-
-
0031047886
-
Clinical pharmacology of carboplatin administered in combination with paclitaxel
-
LJC van Warmerdam MT Huizing G Giaccone PE Postmus WW Bokkel Huinink N van Zandwijk 1997 Clinical pharmacology of carboplatin administered in combination with paclitaxel Semin Oncol 24 1 Suppl 2 S2 (Pubitemid 27113604)
-
(1997)
Seminars in Oncology
, vol.24
, Issue.SUPPL. 2
-
-
Van Warmerdam, L.J.C.1
Huizing, M.T.2
Giaccone, G.3
Postmus, P.E.4
Huinink, W.W.T.B.5
Van Zandwijk, N.6
Koolen, M.G.J.7
Helmerhorst, T.J.M.8
Van Der Vijgh, W.J.F.9
Veenhof, C.H.N.10
Beijnen, J.H.11
-
15
-
-
4243825646
-
Validated method for the determination of carboplatin in biological fluids by Zeeman atomic absorption spectrometry
-
LJC Van Warmerdam O Van Tellingen RAA Maes JH Beijnen 1995 Validated method for the determination of carboplatin in biological fluids by Zeeman atomic absorption spectrometry Fresenius J Anal Chem 351 777 781
-
(1995)
Fresenius J Anal Chem
, vol.351
, pp. 777-781
-
-
Van Warmerdam, L.J.C.1
Van Tellingen, O.2
Maes, R.A.A.3
Beijnen, J.H.4
-
17
-
-
0029038845
-
The log transformation is special
-
ON Keene 1995 The log transformation is special Stat Med 14 8 811 819
-
(1995)
Stat Med
, vol.14
, Issue.8
, pp. 811-819
-
-
Keene, O.N.1
-
19
-
-
0025260145
-
Pharmacokinetics of ranitidine in morbidly obese women
-
RL Davis RW Quenzer HP Bozigian CW Warner 1990 Pharmacokinetics of ranitidine in morbidly obese women DICP 24 11 1040 1043
-
(1990)
DICP
, vol.24
, Issue.11
, pp. 1040-1043
-
-
Davis, R.L.1
Quenzer, R.W.2
Bozigian, H.P.3
Warner, C.W.4
-
22
-
-
0027982027
-
Vancomycin pharmacokinetics in a patient population: Effect of age, gender, and body weight
-
MP Ducharme RL Slaughter DJ Edwards 1994 Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight Ther Drug Monit 16 5 513 518 (Pubitemid 24296745)
-
(1994)
Therapeutic Drug Monitoring
, vol.16
, Issue.5
, pp. 513-518
-
-
Ducharme, M.P.1
Slaughter, R.L.2
Edwards, D.J.3
-
27
-
-
22844432094
-
Estimation of renal function in subjects with normal serum creatinine levels: Influence of age and body mass index
-
DOI 10.1053/j.ajkd.2005.05.011, PII S0272638605006256
-
JC Verhave P Fesler J Ribstein CG Du A Mimran 2005 Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index Am J Kidney Dis 46 2 233 241 (Pubitemid 41040351)
-
(2005)
American Journal of Kidney Diseases
, vol.46
, Issue.2
, pp. 233-241
-
-
Verhave, J.C.1
Fesler, P.2
Ribstein, J.3
Du Cailar, G.4
Mimran, A.5
-
29
-
-
36048936308
-
Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese
-
DOI 10.1200/JCO.2007.11.2938
-
A Sparreboom AC Wolff RH Mathijssen E Chatelut EK Rowinsky J Verweij 2007 Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese J Clin Oncol 25 30 4707 4713 (Pubitemid 350086471)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.30
, pp. 4707-4713
-
-
Sparreboom, A.1
Wolff, A.C.2
Mathijssen, R.H.J.3
Chatelut, E.4
Rowinsky, E.K.5
Verweij, J.6
Baker, S.D.7
-
30
-
-
0031155476
-
How to predict carboplatin clearance from standard morphological and biological charactersties in obese patients
-
S Benezet R Guimbaud E Chatelut C Chevreau R Bugat P Canal 1997 How to predict carboplatin clearance from standard morphological and biological characteristics in obese patients Ann Oncol 8 6 607 609 (Pubitemid 127746495)
-
(1997)
Annals of Oncology
, vol.8
, Issue.6
, pp. 607-609
-
-
Benezet, S.1
Guimbaud, R.2
Chatelut, E.3
Chevreau, C.4
Bugat, R.5
Canal, P.6
-
31
-
-
0141730421
-
Individualised dosing strategy for high-dose carboplatin in patients with germ cell cancer
-
DOI 10.1038/sj.bjc.6601215
-
C Kloft W Siegert U Jaehde 2003 Individualised dosing strategy for high-dose carboplatin in patients with germ cell cancer Br J Cancer 89 5 787 794 (Pubitemid 37175796)
-
(2003)
British Journal of Cancer
, vol.89
, Issue.5
, pp. 787-794
-
-
Kloft, C.1
Siegert, W.2
Jaehde, U.3
|